ABL Texcell Diagnostics SA (ABLD.PA) News
Track canonical SquawkNews coverage tagged to ABLD.PA, ABL Texcell Diagnostics SA. This hub brings together deduplicated headlines about paris, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 4 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
M
ABL Texcell Diagnostics Signs Letter of Intent to Acquire Vela Diagnostics Activities
ABL Texcell Diagnostics said it signed a non-binding letter of intent to acquire 100% of Vela Diagnostics' activities in Singapore and the U.S. There will be no change in control or governance of ABL Texcell Diagnostics
EQUITY | Sep 21, 2026, 05:58 PM UTC
M
ABLD Diagnostics signs LOI to buy Vela Diagnostics units
ABLD Texcell Diagnostics signed a non-binding letter of intent to buy Vela Diagnostics’ operations in Singapore and the US: 100% of Vela Operations Singapore and Vela Diagnostics USA from VDH Holding. Completion is subje
MNA | Sep 21, 2026, 05:03 PM UTC
M
ABL Texcell Diagnostics signs letter of intent to acquire Vela Diagnostics assets
ABL Texcell Diagnostics has signed a non-binding letter of intent to acquire 100% of Vela Operations Singapore and Vela Diagnostics USA. The company aims to consolidate an integrated international platform covering EMEA,
EQUITY | Sep 21, 2026, 05:03 PM UTC
L
ABL Diagnostics cuts cash allocation to liquidity contract by EUR 50,000
ABL Diagnostics cut cash allocated to its liquidity contract with Invest Securities by EUR 50,000 on Sept. 18, 2026. Post-adjustment resources stood at 27,852 shares, EUR 43,873.58 in cash at the market close. At the Jun
EQUITY | Sep 18, 2026, 06:02 PM UTC